Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Vitamin D might help regulate insulin in the body, but taking Vitamin D supplements doesn't clearly prevent or improve type 2 diabetes. More research is needed.

Black and Hispanic women are more likely to have alopecia areata than white women.

GLPLS and LPP are variants of lichen planus.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

BMP2 helps hair follicle stem cells become specialized by increasing PTEN, which causes autophagy.

Hair thinning causes stem cell loss through a process involving Piezo1, calcium, and TNF-α.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Ruxolitinib helped a man regrow his beard after years of hair loss.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Mogamulizumab can cause hair loss and skin rashes.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.